BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Jyong Biotech Strengthens Preventive Medicine Position With Positive Phase II Data And Asian Expansion

Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modul...

February 16, 2026 | News

HanchorBio Secures FDA Orphan Drug Designation For HCB101 In Gastric Cancer

First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnolog...

February 16, 2026 | News

WuXi Biologics And HanchorBio Inc. Sign Strategic Collaboration To Advance Next Generation Fusion Biologics

WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a globa...

January 27, 2026 | News

Formosa Pharmaceuticals Secures Strategic Korea Commercial Partner For Its FDA Approved Ophthalmic Therapy

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Sam...

January 13, 2026 | News

Nuclera Secures First Commercial Sales In Asia With Landmark Installations In Taiwan

Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asi...

January 08, 2026 | News

ScinoPharm Taiwan Becomes First In Country To Secure US FDA Approval For Multiple Sclerosis Injection

ScinoPharm Taiwan announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Gl...

January 06, 2026 | News

SoluPet Partners With CHC To Launch Canine Cognitive Health Solution In Taiwan

SoluPet, the data and science-driven pet cognitive health company developing advanced cognitive-aging support for senior dogs, today announc...

December 10, 2025 | News

Bora Pharmaceuticals Forms Strategic Alliance with Corealis Pharma to Streamline Drug Development

Partnership creates simplified pathway from early development to commercial launch Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader ...

December 10, 2025 | News

Formosa Pharmaceuticals Grants Exclusive ASEAN Rights For APP13007 To Rxilient Medical

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Rxil...

December 04, 2025 | News

Amaran Biotech Achieves FDA Acknowledgement for Type II DMF of AB801 Vaccine Adjuvant

Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vacc...

December 03, 2025 | News

EirGenix and Sandoz Sign USD 152 Million Global Deal for Pertuzumab Biosimilar

EirGenix Inc. announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQ...

November 13, 2025 | News

Hasten Biopharmaceutical Completes 70 Marketing Authorization Transfers and Builds End-to-End Commercial Network Across Asia-Pacific

Hasten Biopharmaceutical Co., Ltd. ("Hasten") announced that while completing 70 Marketing Authorization Transfers (MAT) for its Asia-Pacific pro...

November 05, 2025 | News

Nielsen BioSciences and Maruho Expand Licensing Agreement for CANDIN Across Key Asian Markets

Expansion of licensing agreement extends CANDIN’s development to key Asian growth markets including China, South Korea and Taiwan--and broadens the...

October 27, 2025 | News

Asia University and NucleicAI Forge Alliance to Build Taiwan’s First Sovereign AI Life Science Data Platform

Asia University will partner with NucleicAI LLC, a next-generation platform and data company specializing in AI-driven genomics, precision m...

October 15, 2025 | News

Stay Connected